Medical Science Liaison (Central Italy)- Award winning, global mid-sized pharmaceutical company- Competitive salary + benefits package

Seeking a skilled

MSL

to cover

Central Italy

, preferably based in Rome. You will cover the operational area of Marche, Umbria and Lazio. This role involves engaging with key opinion leaders (KOLs) and contributing to advancements in

infectious diseases

specialty care

.

Key Responsibilities:Develop and maintain a comprehensive list of healthcare professionals (HCPs) and key external experts (KEEs), ensuring effective territory coverage and engagement planning.Share emerging on-label data and disease-related information with HCPs in a scientific, objective,



and balanced manner.Collaborate with KEEs/HCPs in scientific initiatives to enhance disease understanding, including speaker identification and preparation, clinical trials, and investigator-initiated trials (IITs).Provide non-promotional scientific support to various activities such as hospital formulary listings, payer engagements, and speaker training sessions.Respond to unsolicited medical inquiries in an accurate and timely manner.Gather insights from scientific interactions with HCPs to inform internal stakeholders about clinical practice trends and knowledge gaps.Deliver therapeutic area and product training to internal teams where applicable.Stay updated on the latest scientific knowledge and industry developments through ongoing training and professional development.

Key Qualifications & Skills:Degree in life sciences, medicine or pharmacyFluency in Italian

and a high level of proficiency in written and spoken

English3+ years’

experience as an MSLDesired experience in

infectious diseases, intensive care or haemato-oncology.Comprehensive understanding of the pharmaceutical industry, prescription processes,



and drug distribution in Italy.Ability to work cross-functionally and build strong professional relationships.

If this opportunity interests you, please submit your CV to to apply now. This organisation is looking to welcome the new MSL onboard ASAP.